MedTrace Logo

The Effect of Higher Protein Dosing in Critically Ill Patients

NCT03160547 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1329

Last updated 2022-03-28

No results posted yet for this study

Summary

The investigator will investigate the effects of higher protein/amino acid dosing (≥2.2 g/kg/d) vs usual protein/amino acid dosing (≤1.2 g/kg/d) on clinical outcomes in nutritionally high risk ill patients.

Conditions

  • Critical Illness
  • Malnutrition

Interventions

OTHER

Usual Protein/Amino Acid Group

Protein targets will be set using pre-ICU dry actual weight. For patients with BMI \>30, ideal body weight based on a BMI of 25 will be used. We will endorse the guidelines for energy targets set forth by ASPEN/SCCM, especially as it pertains to the obese patient.

OTHER

Higher Protein/Amino Acid Group

Protein targets will be set using pre-ICU dry actual weight. For patients with BMI \>30, ideal body weight based on a BMI of 25 will be used. We will endorse the guidelines for energy targets set forth by ASPEN/SCCM, especially as it pertains to the obese patient.

Sponsors & Collaborators

  • Clinical Evaluation Research Unit at Kingston General Hospital

    lead OTHER

Principal Investigators

  • Daren K Heyland, MD · Clinical Evaluation Research Unit

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-21
Primary Completion
2021-12-03
Completion
2021-12-03

Countries

  • United States
  • Argentina
  • Australia
  • Brazil
  • Canada
  • Greece
  • Hong Kong
  • India
  • Iran
  • Japan
  • Malaysia
  • Mexico
  • Panama
  • Puerto Rico
  • Saudi Arabia
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03160547 on ClinicalTrials.gov